Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
about
Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolideMarine Diterpenoids as Potential Anti-Inflammatory AgentsPlant-derived immunomodulators: an insight on their preclinical evaluation and clinical trialsNADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTSEvaluation of traditional medicines for neurodegenerative diseases using Drosophila modelsQuantWorm: a comprehensive software package for Caenorhabditis elegans phenotypic assaysTriptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cellsPristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation PathwayQuantitative proteomics reveals cellular targets of celastrolDemethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB PathwayMerging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foodsMolecular Analysis of Chinese Celastrus and Tripterygium and Implications in Medicinal and Pharmacological StudiesNADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action.The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfallsPristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2.Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordiiSulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibitionComparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety.Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunctionTriptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signalingTriptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii.Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy PathwayProtective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysisAnti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells.Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis.Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.Triptolide exhibits anti-inflammatory, anti-catabolic as well as anabolic effects and suppresses TLR expression and MAPK activity in IL-1β treated human intervertebral disc cellsSynergistic antitumor activity of gemcitabine combined with triptolide in pancreatic cancer cells.Extracts of Tripterygium wilfordii Hook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled Trials.Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB SignalingKunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.Triptolide induces lysosomal-mediated programmed cell death in MCF-7 breast cancer cells.Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation.Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.Technology for improving the bioavailability of small molecules extracted from traditional Chinese medicines.
P2860
Q24302071-1D0AAFE4-A458-4870-9B7F-521DBD080B69Q26779952-55400A11-7B4F-4315-A921-C4B962005A48Q26784434-F314B8F6-49D6-48A7-8142-544A6836D7CCQ26821775-661D6627-AD3C-4409-BE6E-AA944BF9766EQ27027455-494B066A-0B06-4142-A748-28AF40FDD80CQ27334593-ECBF2CB6-2C4A-42AC-BF50-2E888AA4283DQ28385576-2388F298-479B-422D-BD56-C6928F92811BQ28386691-69CA1361-6D8B-42BC-8A29-6A6FCEED853AQ28477634-24F2D8A0-1C23-4523-BA8E-A1BE498C2801Q28546765-E09EB0C9-5685-4948-8094-7DCF6A041CD9Q28743626-79916AFC-3B4B-4975-AF69-2F2E90CEC1DBQ28817436-C1D0109D-B99A-4780-9CF3-285A567D2455Q30155581-99EFF8E5-9C35-424F-85C8-0943EE93016CQ33632757-A9AC76F8-F68D-4E39-9922-A28288BEDD81Q33636979-E98F5E3D-6E39-4170-A9AF-5C41B9BF5254Q34014598-1F438F89-82B6-435E-B242-7A15DD8880DFQ34120438-A373A4FA-16D0-43D4-9070-1A0981A2C033Q34124686-FA87B477-551F-420D-AE16-C2DBFB261165Q34167879-65392DF6-D80B-49FA-AEBE-7A5410DA6547Q34502672-AF1CBF08-2362-4D36-A2AB-65A4FC00DBE2Q34518826-35D076E8-7167-42A0-9B83-6743A5180428Q34631363-EAEB1227-8E66-4AE7-9EA2-2093A0B32347Q34719818-D50EEF7D-2FA1-4C22-8815-05A76E5831D8Q35151115-E758CAE6-2575-4BA9-9CB8-55E23FFCB47EQ35566381-79B82F12-76E6-4365-ADF4-19CA92E9D57CQ35837162-2DA68D39-5A69-4612-9E8F-32730C9EB21FQ35851959-D948040A-C9A6-484A-89B6-2F21C49838C3Q36076386-A334A05B-8244-4937-9FEB-C9CF62BD502DQ36119213-34D049DE-C418-4436-B25E-B43881ABF8E5Q36363376-8E2B01D4-751D-4E9F-B73C-BCB0AE2E4D6DQ36370715-47702870-BDAC-439A-8EA4-9D680CEA8044Q36502723-6418A63E-5B09-48C0-B85E-5884897FCE8EQ36825562-8D47CEB4-C7D4-43DC-89CD-C50194230B78Q36896228-4AF03EBF-3CB3-4D13-9845-62123B33243EQ37036012-76C1D302-20BC-4A16-83A5-1A5B593FAD7AQ37118152-C69253B4-A579-451E-BEA7-72112A1BCC04Q37169780-200BFBCB-FB30-433B-8AD8-4B515E138DF4Q37424051-8F0C51D0-65B7-4F63-8067-F64670DDA080Q37534942-4103DB4B-0C7B-4DE0-954D-CD13DB10D027Q37620367-C6B7E1C6-BB02-4865-98DB-5A7C737F8315
P2860
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@ast
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@en
type
label
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@ast
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@en
prefLabel
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@ast
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@en
P2093
P2860
P1433
P1476
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
@en
P2093
Anita M Brinker
Ilya Raskin
Peter E Lipsky
P2860
P304
P356
10.1016/J.PHYTOCHEM.2006.11.029
P577
2007-01-23T00:00:00Z